In honor of National Women’s Health Month, Dr. Goad wants to make sure postmenopausal women are aware of a new study from the Case Western Reserve University School of Dental Medicine and the Cleveland Clinic that affects how they care for their teeth.
The study was conducted by comparing women who took bone-strengthening bisphosphonate therapies for osteoporosis with those who did not take the medicine. While they originally set out to investigate the effects these drugs have on jaw bone deterioration, researchers ended up with findings that related to all post-menopausal women.
All of the women from both of the groups went to at least two dental checkups a year and brushed and flossed twice daily, according to the American Dental Association oral health standards. However, at the end of the study, they all had increased dental plaque, which is a major factor in determining the strength of the jaw bone.
Menopausal and post-menopausal women who are at risk for osteoporosis are also at risk for periodontal disease and the deterioration of bone density in the jaw. Any benefits from bone-strengthening medications can be counteracted by plaque, which contributes to gum disease and bone loss. If bone loss is not controlled, women can lose their teeth permanently.
The best way to avoid these complications is to see Dr. Goad to outline a treatment and oral health plan that is right for you. Contact us today to schedule your appointment!